Recon: GSK sees sales growth in 2022; EMA sets up new real-world data center
ReconMichael Mezher
BiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyReconMichael MezherBiologicsBiotechnologyDiagnosticsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy